-
21
LAMB1 downregulation suppresses glioma progression by inhibiting aerobic glycolysis through regulation of the NF-κB/HK2 axis
Published 2025-02-01Subjects: Get full text
Article -
22
-
23
Sphingosine kinase 1 promotes M2 macrophage infiltration and enhances glioma cell migration via the JAK2/STAT3 pathway
Published 2025-02-01Subjects: Get full text
Article -
24
MYH9 promotes malignant progression of glioma cells through regulating β-catenin stability via epithelial-mesenchymal transition signaling pathway
Published 2025-02-01“…This MYH9/β-catenin/EMT pathway represents a new molecular mechanism involved in the invasion promotion in gliomas. Our findings also demonstrated that MYH9 was crucial for inducing glioma cell migration. …”
Get full text
Article -
25
Preoperative prediction of IDH genotypes and prognosis in adult-type diffuse gliomas: intratumor heterogeneity habitat analysis using dynamic contrast-enhanced MRI and diffusion-weighted imaging
Published 2025-02-01Subjects: “…Adult-type diffuse glioma…”
Get full text
Article -
26
-
27
-
28
-
29
Distinguishing glioblastoma from brain metastasis; a systematic review and meta-analysis on the performance of machine learning
Published 2025-02-01Subjects: Get full text
Article -
30
Valproic acid targets IDH1 mutants through alteration of lipid metabolism
Published 2024-08-01“…Both VPA and a selective FASN inhibitor TVB-2640 rewired the lipidome and promoted apoptosis in an IDH1 MT but not in an IDH1 WT glioma cell line. We further find that HDACs are involved in the regulation of lipogenic genes and HDAC6 is particularly important for the regulation of FASN in IDH1 MT glioma. …”
Get full text
Article -
31
Cuproptosis-related lncRNAs and genes: Potential markers for glioblastoma prognosis and treatment.
Published 2025-01-01“…Despite the availability of various treatment options, glioblastoma (GBM) remains an extremely aggressive form of glioma with a poor prognosis. In recent studies, regulatory cell death (RCD) has been identified as an effective mechanism to suppress glioma. …”
Get full text
Article -
32
FDA-approved kinase inhibitors: a promising therapeutic avenue for traumatic brain injury
Published 2024-12-01Get full text
Article -
33
Infantile (congenital) anaplastic intracranial solitary fibrous tumor/hemangiopericytoma—A case report with brief literature review
Published 2023-07-01“…The magnetic resonance imaging (MRI) showed a space-occupying lesion measuring 8.2 cm × 7 cm × 6.9 cm in the fronto-temporo-parietal region with a clinical diagnosis of glioma/atypical teratoid rhabdoid tumor (ATRT). The microscopy revealed a spindle cell tumor arranged in a patternless pattern with variable cellularity, increased mitosis, and areas of coagulative necrosis. …”
Get full text
Article -
34
Identification and validation of TSPAN13 as a novel temozolomide resistance-related gene prognostic biomarker in glioblastoma.
Published 2025-01-01“…We assessed cell proliferation, migration, and invasion capabilities through in vitro assays (including CCK-8, Edu, wound healing, and transwell assays) and quantitatively analyzed TSPAN13 expression levels in clinical glioma samples using tissue microarray immunohistochemistry. …”
Get full text
Article -
35
Enhanced Brain Tumor MRI Classification Using Stationary Wavelet Transform, ResNet50V2, and LSTM Networks
Published 2025-01-01“…After that a Long Short Term Memory network receives the features. that will model the dependencies in the feature space and classifies into four categories: Glioma, Meningioma, Pituitary tumors, and No Tumor. …”
Get full text
Article -
36
Clinical relevance and druggability of sole reciprocal kinase fusions: A large‐scale study
Published 2024-09-01“…Results Our findings revealed 51 instances (2.57%) of sole reciprocal fusions, predominantly in lung (57%), colorectal (14%), and glioma (10%) cancers. Comparative analysis with an MSKCC cohort confirmed the prevalence in diverse cancer types and identified unique fusion partners and chromosomal locales. …”
Get full text
Article -
37
Hybrid azole-based conjugates as upcoming anticancer and antimicrobial agents
Published 2023-11-01“…The anticancer activity of the compounds was assessed through i) proliferation assays for HCT116, MCF-7, and A375 human cell lines [cells were treated with serial dilutions of compounds and the effect on cell propagation was evaluated by sulforhodamine B (SRB) assay]; ii) antiproliferative and cytotoxic assays for glioma-type cell lines A172 (glioblastoma), U87 (brain-likely glioblastoma), and H4 (neuroglioma; cells were treated with diverse concentrations and the cell viability was assessed using a modified Alamar blue® assay). …”
Get full text
Article